Hikma Pharmaceuticals USA Inc. has recalled approximately 2,100,646 units of Sodium Chloride Injection USP 0.9% (2 mL vials) used as a sterile diluent. This prescription drug was recalled because test results showed the pH levels were outside of the required safety specifications, which could affect the stability or efficacy of the medication being diluted. This nationwide recall includes specific lots of single-dose vials manufactured by West-ward in Eatontown, New Jersey.
Using a sterile diluent with incorrect pH levels can potentially cause irritation at the injection site or change the effectiveness of the drug it is mixed with. While no injuries have been reported, the deviation from set chemical standards poses a risk to patient safety during medical procedures.
Return unused product for refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.